T-SPOT.TB interferon-g release assay performance in healthcare worker screening at nineteen U.S. Hospitals

American Journal of Respiratory and Critical Care Medicine

Volumn 192, Issue 3, 2015, Pages 367-373

  King, Thomas C ^a   Upfal, Mark ^b   Gottlieb, Andrew ^c   Adamo, Philip ^d   Bernacki, Edward ^e   Kadlecek, Chris P ^f   Jones, Jeffrey G ^g   Humphrey Carothers, Frances ^h   Rielly, Albert F ^c   Drewry, Pamela ⁱ   Murray, Kathy ^j   DeWitt, Marcie ^k   Matsubara, Janet ^l   O'Dea, Louis ^l   Balser, John ^m   Wrighton Smith, Peter ^l  

^a SAINT VINCENT HOSPITAL   (United States)

^b DETROIT MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d University of Massachusetts   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f TEXAS CARDIAC ARRHYTHMIA INSTITUTE   (United States)

^g St Francis Hospital   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ MEDICAL CITY DALLAS HOSPITAL   (United States)

^j Sonora Regional Medical Center   (United States)

^k Employee Health Baptist Health Louisville   (United States)

^l Oxford Immunotec   (United States)

^m Veristat   (United States)

more..

Author keywords

Conversion; LTBI; Reversion; Serial testing; Tuberculosis screening

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENDER; HEALTH CARE PERSONNEL; HUMAN; INCIDENCE; INTERFERON GAMMA RELEASE ASSAY; LUNG TUBERCULOSIS; MALE; MASS SCREENING; PRIORITY JOURNAL; RELIABILITY; TUBERCULIN TEST; UNITED STATES; EVALUATION STUDY; HOSPITAL; HOSPITAL PERSONNEL; MIDDLE AGED; PROCEDURES; REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA; TUBERCULOSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HOSPITALS; HUMANS; INTERFERON-GAMMA RELEASE TESTS; MALE; MASS SCREENING; MIDDLE AGED; PERSONNEL, HOSPITAL; REPRODUCIBILITY OF RESULTS; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES; YOUNG ADULT;

EID: 84938899208     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201501-0199OC     Document Type: Article

References (23)

1. Jensen PA, Lambert LA, Iademarco MF, Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005;54:1-141.
2. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using interferon gamma release assays to detect infection-United States, 2010. MMWR Recomm Rep 2010;59:1-25.
3. Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, Weinfurter P, Wang Y, Cronin W, Hirsch-Moverman Y, Teeter LD, et al.; Tuberculosis Epidemiologic Studies Consortium. Interferon-g release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med 2014;189:77-87.
4. Joshi M, Monson TP, Joshi A, Woods GL. IFN-g release assay conversions and reversions. Challenges with serial testing in U.S. health care workers. Ann Am Thorac Soc 2014;11:296-302.
5. Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 2012;67:62-70.
6. Slater ML, Welland G, Pai M, Parsonnet J, Banaei N. Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers. Am J Respir Crit Care Med 2013;188:1005-1010.
7. Gandra S, Scott WS, Somaraju V, Wang H, Wilton S, Feigenbaum M. Questionable effectiveness of the QuantiFERON-TB Gold Test (Cellestis) as a screening tool in healthcare workers. Infect Control Hosp Epidemiol 2010;31:1279-1285.
8. Bennett DE, Courval JM, Onorato I, Agerton T, Gibson JD, Lambert L, McQuillan GM, Lewis B, Navin TR, Castro KG. Prevalence of tuberculosis infection in the United States population: the National Health and Nutrition Examination Survey, 1999-2000. Am J Respir Crit Care Med 2008;177:348-355.
9. Fong KS, Tomford JW, Teixeira L, Fraser TG, van Duin D, Yen-Lieberman B, Gordon SM, Miranda C. Challenges of interferon-g release assay conversions in serial testing of health-care workers in a TB control program. Chest 2012;142:55-62.
10. Zwerling A, Benedetti A, Cojocariu M, McIntosh F, Pietrangelo F, Behr MA, Schwartzman K, Menzies D, Pai M. Repeat IGRA testing in Canadian health workers: conversions or unexplained variability? PLoS One 2013;8:e54748.
11. Herrera V, Yeh E, Murphy K, Parsonnet J, Banaei N. Immediate incubation reduces indeterminate results for QuantiFERON-TB Gold in-tube assay. J Clin Microbiol 2010;48:2672-2676.
12. Doberne D, Gaur RL, Banaei N. Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection. J Clin Microbiol 2011;49:3061-3064.
13. Joshi M, Monson TP, Woods GL. Use of interferon-gamma release assays in a health care worker screening program: experience from a tertiary care centre in the United States. Can Respir J 2012;19: 84-88.
14. Gaur RL, Pai M, Banaei N. Impact of blood volume, tube shaking, and incubation time on reproducibility of QuantiFERON-TB gold in-tube assay. J Clin Microbiol 2013;51:3521-3526.
15. Tagmouti S, Slater M, Benedetti A, Kik SV, Banaei N, Cattamanchi A, Metcalfe J, Dowdy D, van Zyl Smit R, Dendukuri N, et al. Reproducibility of interferon gamma (IFN-g) release assays: a systematic review. Ann Am Thorac Soc 2014;11:1267-1276.
16. Couturier MR, Myatt R, Dorn D, Yang DT, Pitstick N. Defective antigen tubes generate false-positive QuantiFERON tuberculosis test results. Clin Infect Dis 2014;59:1649-1650.
17. Bienek DR, Chang CK. Evaluation of an interferon-gamma release assay, T-SPOT.TB, in a population with a low prevalence of tuberculosis. Int J Tuberc Lung Dis 2009;13:1416-1421.
18. Wang SH, Powell DA, Nagaraja HN, Morris JD, Schlesinger LS, Turner J. Evaluation of a modified interferon-gamma release assay for the diagnosis of latent tuberculosis infection in adult and paediatric populations that enables delayed processing. Scand J Infect Dis 2010;42:845-850.
19. Talbot EA, Harland D, Wieland-Alter W, Burrer S, Adams LV. Specificity of the tuberculin skin test and the T-SPOT.TB assay among students in a low-tuberculosis incidence setting. J Am Coll Health 2012;60:94-96.
20. Mancuso JD, Mazurek GH, Tribble D, Olsen C, Aronson NE, Geiter L, Goodwin D, Keep LW. Discordance among commercially available diagnostics for latent tuberculosis infection. Am J Respir Crit Care Med 2012;185:427-434.
21. Wrighton-Smith P, Sneed L, Humphrey F, Tao X, Bernacki E. Screening health care workers with interferon-g release assay versus tuberculin skin test: impact on costs and adherence to testing (the SWITCH study). J Occup Environ Med 2012;54:806-815.
22. CDC. Reported tuberculosis in the United States, 2013. Atlanta, GA: US Department of Health and Human Services; 2014.
23. CDC. Reported tuberculosis in the United States, 2011. Atlanta, GA: US Department of Health and Human Services; 2012.